Закажите звонок

Отправить
×

Спасибо!

Ваша заявка успешно отправлена. В ближайшее время с Вами свяжется наш специалист.
×

List of publications for

×

European Science Review, Issue 9-10/2016

The basics of local clinical manifestations of superficial bladder cancer

DOI: https://doi.org/10.29013/ESR-16-9.10-75-77

Pages: 75 - 77

Authors: Babakulov S. H., Navruzov S. N., Babakulova S. H.

Abstract: According to a study The stage of the patients in both groups expressed LIR were observed. Mainly observed mild LIR bladder of 63.7% and 66.7% respectively of the studied groups. In contrast, with T1 stage were pronounced bladder LIR, which in the main group amounted to 73.2% in the control — 81,8%. Therefore, reasonable LIR in the main group was 16.1%, in the control of 36.3%. The results indicate the existence of a relationship between LIR and the tumor stage in the bladder

Keywords: bladder cancer, probiotics, transurethral resection, microflora, relapse

Bibliography:
1. Matos T., Cufer T., Cervek J. et al. Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organsparing
approach). Int. J. Radiat. Oncol. Biol. Phys. – 2000;46 (2):403–9.
2. Van Rhijn B. W., Burge M., Lotan Y. et al. Recurrence and progression of disease in non-muscular-invasive bladder cancer: from epidemiology
to treatment strategy//Eur. Urology. – 2009. – Vol.56, No 3. – P. 430–442.
3. Kanmani P., Satis-Kumar R., Yuvaraj N. et al. Probiotics and its functionality valuable products-a review.//Critical reviews in food
science and nutrition. – 2013. – Vol.53, No 6. – P. 641–658.
4. Kawai K., Miyazaki J., Joraki A. et al. BCG immunotherapy for bladder cancer: current understanding and perspectives on engineered
BCG vaccine//Eur. Urology. – 2009. – Vol.56, No 3. – P. 430–442.
5. Cancer Science. – 2013. – Vol. 14, No 1. – P. 22–27.
A spectrum of the opportunistic and associated diseases in patients with natural course of the HIV-infection
77
6. Babjuk M., Burger M., Zigeuner R. et al.//EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update –
2013//Eur. Urology. – 2013. – Vol. 64, No 4. – P. 639–653.
7. Ikeda M., Motoshima T., Kurosawa K. et al. Efficacy and safety maintenance intravesucal instillation therapy with dacillisCalmette-
Guerin and epirubicin for non-muscle-invasive bladder cancer.//Hinyokika Kiyo. – 2013. – Vol. 59, No 3. – P. 153